1. General Office of the National Health Commission of the people’s Republic of China, Office of the National Administration of Traditional Chinese Medicine. Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition). China Medicine 2020; 15(6): 801–805
2. Guidelines Working Committee of Chinese Society of Clinical Oncology. Lymphoid Malignancies (2020 edition). Beijing: People’s Medical Publishing House, 2020
3. NCCN Guidelines Insights: B-Cell Lymphomas, Version 2.2020. 2020. Available at NCCN website
4. Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, Brown J, Chanan-Khan AA, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lim MS, Ma S, Malek S, Mato A, Mosse C, Shadman M, Siddiqi T, Stephens D, Sundaram S, Wagner N, Dwyer M, Sundar H. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2020; 18(2): 185–217
5. NCCN Clinical Practice Guidelines in Oncology. Waldenstrom’s macroglobulinemia/lymphoplasmacytic lymphoma. Version 1.2021. Fort Washington: National Comprehensive Cancer Network, 2021